Bringing the fundamentals into focus…
Back to CRISPR Therapeutics AG
How CRISPR Therapeutics AG stacks up
CRSP · against 237 other Healthcare companies of similar size
Overall
27/ 100
Near the bottom of its peers.
Ranked #227 of 238 · scores higher than 4% of peers
Bars: peers in each 10-point band of the overall score12 peers with an overall score of 20–29, including CRSP · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around CRSP| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 3 | 19.7B HKD (≈$2.5B) | 84 | 84 | 98 | 87 | 0 / 2 | |
| 3 | 2.7B USD | 84 | 75 | 98 | 99 | 1 / 2 | |
| 5 | 18.3B DKK (≈$2.7B) | 81 | 86 | 74 | 86 | 0 / 2 | |
| 222 | 9.3B USD | 29 | 8 | 65 | 21 | 2 / 2 | |
| 224 | 8.4B USD | 28 | 8 | 74 | 21 | 2 / 2 | |
| 224 | 8.5B USD | 28 | 8 | 37 | 26 | 1 / 2 | |
| 224 | 3.7B USD | 28 | 8 | 6 | 4 | 0 / 2 | |
| 227 | 4.8B USD | 27 | 8 | 5 | 5 | 0 / 2 | |
| 227 | 3.1B USD | 27 | 8 | 12 | 3 | 0 / 2 | |
| 229 | 31.0B CNY (≈$4.3B) | 26 | 0 | 4 | 29 | 0 / 2 | |
| 229 | 8.7B USD | 26 | 8 | 78 | 2 | 2 / 2 | |
| 231 | 3.7B USD | 24 | 8 | 9 | 1 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score